Literature DB >> 788548

Train-of-four fade and edrophonium antagonism of neuromuscular block by succinylcholine in man.

C Lee.   

Abstract

Thumb twitch in response to train-of-four stimulation (2 Hz for 2 sec) of the ulnar nerve was measured in 36 patients anesthetized with halothane and N2O and paralyzed with succinylcholine chloride (SCC). Train-of-four fade was detected whenever a block was produced. The train-of-four ratio decreased with continued exposure to SCC. Edrophonium effect was predictable by the train-of-four ratio in a semiquantitative manner, a high ratio predicting block enhancement and a low ratio, antagonism. When calculated at 30 to 50 percent recovery (from complete block), a train-of-four ratio of 0.4 or less reliably predicts antagonism. The magnitude of antagonism is also predictable in a semiquantitative manner, although complete antagonism cannot be ascertained. The lower the ratio, the more effective the antagonism becomes. Train-of-four fade, therefore, appears to be a consistent and sensitive quantitative sign of phase II neuromuscular block by SCC in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788548

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion.

Authors:  F Donati; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1982-01

2.  A Century of Technology in Anesthesia & Analgesia.

Authors:  Jane S Moon; Maxime Cannesson
Journal:  Anesth Analg       Date:  2022-07-15       Impact factor: 6.627

Review 3.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

4.  Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.

Authors:  M E Futter; F Donati; A S Sadikot; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.